5th Annual Gene Therapy Analytical Development Summit 2023

2023/11/27

Meet us at GTAD in Boston

The 5thAnnual Gene Therapy Analytical Development Summit is the industry’s leading meeting to discover and discuss how the latest analytical tools are being developed and applied to guarantee the consistency, quality, and safety of gene therapy products.

Meet our colleagues Evelyn Eggenstein and Jörg Müller at Booth No. 19.

Join the scientific lecture of Prof. Dr. Gideon Kersten on
"Latest analytical methods for characterization of virus particles in cell and gene therapy products".

The presentation will take place on conference day 2, November, 29, 2023.

Visit event website

Contact us

Contact us

Save time on-site and schedule a face-to-face meeting with our experts, contacting Dr. Jörg Müller upfront.

Phone: +49 89 41 77 60 – 111
Mail: joerg.mueller@coriolis-pharma.com

Dr, Jörg Müller

The Martian Pharmacy

News

Interview with Tim Menzen on Lyphilized Drug Products and the Martian Pharmacy

Tim Menzen in an interview with the medicine maker on the topic of the transportation, storage, and administration of drugs in space

Poster at PDA Conference

News

Poster Presentation: PDA Conference Amsterdam 2024

Join our poster presentation in Amsterdam from June 24-25: Challenges in the Analysis of a Pharmaceutical Lentiviral Vector by Orthogonal Physical (Nano)particle Characterization Techniques

new US entity

News

Coriolis Pharma launches U.S. entity alongside innovative drug product platform service offerings for monoclonal antibodies

Coriolis Pharma announces the launch of a U.S. entity that allows customers to combine the convenience of a local service with the advantages of international expertise. In parallel Coriolis is also launching two novel platform services for developability assessment and pre-formulation screening.

Coriolis offers AUC under GMP

News

Coriolis Pharma Adds Analytical Ultracentrifugation for Release Testing to its Service Offerings

Coriolis Pharma offers Analytical Ultracentrifugation (AUC) for biologics and virus-based drug products from early-stage development to post-market monitoring.

Modeling the future of Lyophilization

News

Modelling The Future Of Lyophilization

Coriolis experts Andrea Arsiccio and Brecht Vanbillemont publish article on lyophilization modelling in "the Medicine Maker".

Donations 2023

News

Coriolis donates to aid organizations

Coriolis spreads the Christmas spirit and donates to organizations that help people in need, fight for a healthy nature, or improve our society as a whole

Tim Menzen

News

Tim Menzen honored by JPharmSci as Outstanding Early Career Scientist

The Editorial Staff and the American Pharmacists Association have been recognizing outstanding outstanding early career scientists for publishing their most original and significant scientific findings ...

Gideon Kersten Leiden University

News

Coriolis Pharma re-establishes Chair in Vaccine development at Leiden University

Leiden University re-appoints Prof. Dr. Gideon Kersten to the Chair in Vaccine development for a third 5-year term.

Coriolis News

News

Coriolis Pharma announces strategic growth partnership with KKR and Frontier Biosolutions

Coriolis Pharma secures investment from KKR to support next steps in growth and to expand global footprint.

Johannes Clemens

News

Coriolis Pharma appoints Johannes Clemens as new Head of Business Development

Coriolis Pharma appoints Johannes Clemens as new Head of Business Development. He will be responsible for expanding Coriolis’ worldwide activities and services, including client business and the establishment of new collaborative partnerships.